121
Participants
Start Date
June 1, 2017
Primary Completion Date
September 30, 2022
Study Completion Date
February 3, 2023
lerapolturev
A single dose of lerapolturev, an oncolytic polio/rhinovirus recombinant
Lomustine
one cycle of oral lomustine
Preston Robert Tisch Brain Tumor Center at Duke University, Durham
Baptist MD Anderson Cancer Center, Jacksonville
University Hospitals Cleveland Medical Center, Cleveland
UCSF Neurological Surgery, San Francisco
Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston
Lead Sponsor
Collaborators (1)
Duke University
OTHER
Istari Oncology, Inc.
INDUSTRY